**Question:** Corpora amylacea is seen in

A. Alzheimer's disease
B. Parkinson's disease
C. Multiple Sclerosis
D. Creutzfeldt-Jakob disease

**Core Concept:** Corpora amylacea are eosinophilic, granular, or nodular structures found in the substantia nigra, a region of the midbrain involved in the control of voluntary movements. They are composed of lipofuscin pigments and are often associated with aging and neurodegenerative diseases.

**Why the Correct Answer is Right:** Corpora amylacea are primarily associated with aging and are a normal finding in the substantia nigra. However, in the context of the question, the correct answer should explain the presence of corpora amylacea in a specific disease. Among the given options, Alzheimer's disease (A) and Parkinson's disease (B) are neurodegenerative disorders that involve the substantia nigra, leading to the accumulation of corpora amylacea.

**Why Each Wrong Option is Incorrect:**

A. Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular plaques (beta-amyloid) and intracellular neurofibrillary tangles (tau protein). Although AD can affect the substantia nigra, corpora amylacea is not a defining feature of Alzheimer's disease.

B. Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to the clinical features of tremors, rigidity, bradykinesia, and postural instability. Corpora amylacea are a common feature of Parkinson's disease due to the accumulation of lipofuscin pigments in the substantia nigra, reflecting neuronal dysfunction and loss.

C. Multiple Sclerosis (MS) is an autoimmune disorder that affects the myelin sheaths of neurons, leading to the clinical features of neurological deficits. Corpora amylacea are not a defining feature of MS, as they are not present in the substantia nigra.

D. Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive, and fatal neurodegenerative disorder characterized by the accumulation of misfolded proteins (prion proteins) in the brain. Corpora amylacea is not a defining feature of Creutzfeldt-Jakob disease, which primarily affects the cerebral cortex and basal ganglia, not the substantia nigra.

**Clinical Pearl:** When assessing a patient with Parkinson's disease, the presence of corpora amylacea in the substantia nigra can be supportive of the diagnosis, although it is not specific to Parkinson's disease alone. In contrast, the absence of corpora amylacea in the substantia nigra might lead to considering other causes of parkinsonism, such as multiple system atrophy or progressive supranuclear palsy.